Treatment of Alzheimer's disease with short- and long-term oral THA and lecithin: a double-blind study

1990 ◽  
Vol 147 (2) ◽  
pp. 239-242 ◽  
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Blind Study ◽  
Double Blind Study ◽  
Double Blind ◽  
Short And Long Term

EHT0202 in Alzheimer's Disease: a 3-Month, Randomized, Placebo- Controlled, Double-Blind Study

2011 ◽  
Vol 999 (999) ◽  
pp. 1-10
Author(s):  
Bruno Vellas ◽  
Olivier Sol ◽  
Peter. J. Snyder ◽  
Pierre-Jean Ousset ◽  
Raphael Haddad ◽  
...  
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Blind Study ◽  
Double Blind Study ◽  
Double Blind

A 24-week, randomized, double-blind study of donepezil in moderate to severe Alzheimer's disease

Neurology ◽  
2001 ◽  
Vol 57 (4) ◽  
pp. 613-620 ◽  
Author(s):  
H. Feldman ◽  
S. Gauthier ◽  
J. Hecker ◽  
B. Vellas ◽  
P. Subbiah ◽  
...  
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Blind Study ◽  
Double Blind Study ◽  
Double Blind

Double Blind Study of Lecithin in Patients with Alzheimer's Disease

1981 ◽  
Vol 26 (6) ◽  
pp. 426-428 ◽  
Author(s):  
M. Fisman ◽  
H. Merskey ◽  
E. Helmes ◽  
J. Mccready ◽  
E.H. Colhoun ◽  
...  
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Serum Levels ◽  
Blind Study ◽  
Double Blind Study ◽  
Double Blind Trial ◽  
Double Blind ◽  
Blind Trial

Twenty-one patients with a diagnosis of Alzheimer's disease completed a double blind trial on lecithin 25 g daily. Equal improvement was noted in both the lecithin and placebo groups. Serum levels of lecithin measured 12-14 hours after its administration were also not increased compared with the levels in control patients. These findings of the ineffectiveness of lecithin inpatients with Alzheimer's disease are discussed in relation to the literature on this subject.

Sign in / Sign up

Export Citation Format

Share Document